Ola (Aleksandra) Wlodek

Ola (Aleksandra) Wlodek has a diverse work experience in the fields of biotechnology and drug discovery. Ola (Aleksandra) is currently serving as the Chief Executive Officer at Constructive Bio since July 2022. Prior to this, Ola worked as the Chief Operating Officer at Reflection Therapeutics, a startup focused on developing therapies for neuroinflammation and severe conditions such as ALS. Ola (Aleksandra) held this role from June 2019 to July 2022 and was responsible for overseeing external research and development projects.

Ola also has experience in founding and being a member of the Next Generation Women's Collective at Ovarian Cancer Action from January 2021 to June 2022. Additionally, they worked as a Senior Scientist at Cambridge Glycoscience, where they played a key role in setting up laboratory facilities and managing operations and HR. Ola held this position from January 2019 to June 2019.

Prior to their time at Cambridge Glycoscience, Ola worked at Isomerase Therapeutics Ltd. in various roles. Ola (Aleksandra) served as a Senior Scientist from January 2014 to May 2018, where they focused on engineering actinomycetes to develop novel natural and polyketide products. Ola also worked as a Synthetic Scientist/Biologist from January 2014 to January 2016 and as a Senior Biologist from January 2016 to May 2018 during their tenure at Isomerase Therapeutics.

Before venturing into industry, Ola pursued their academic career. Ola (Aleksandra) completed their PhD at the Medical Research Council, where they conducted research in an undisclosed timeframe. Prior to that, they obtained their Magister (MSc) in Biotechnology from Jagiellonian University, which they completed from July 2007 to June 2009.

Ola (Aleksandra) Wlodek's education history begins with their obtaining a Master's Degree in Biotechnology from Jagiellonian University, which they completed between 2004 and 2009. Ola (Aleksandra) then pursued further studies at the University of Cambridge, where they completed their Doctor of Philosophy (Ph.D.) in Biological and Biomedical Sciences from 2009 to 2013.

In 2021, Ola enrolled at the University of Warwick - Warwick Business School to pursue an Executive MBA degree, specializing in Entrepreneurship/Entrepreneurial Studies. This program is expected to be completed in 2023.

In terms of additional certifications, Ola obtained the Venture Deals Summer 2020 certification from Kauffman Fellows in August 2020. Prior to that, in April 2019, they received a certification in Patenting in Biotechnology from Coursera.

Taking into account the provided information, it can be concluded that Ola (Aleksandra) Wlodek has a solid educational background, particularly in the fields of Biotechnology and Biological and Biomedical Sciences, and they are currently furthering their knowledge in Entrepreneurship with an Executive MBA. Additionally, they have demonstrated their commitment to continuous learning and professional development through their additional certifications.